We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Paysafe
PSFE
$304M
| $11.5K | ﹤0.01% |
911
-45,939
| -98% | -$628K |
2023 Q1
9 quarters
|
|
1802
SM Energy
SM
$8.94B
| $11.4K | ﹤0.01% |
461
-298,463
| -100% | -$7.23M |
2021 Q3
15 quarters
|
|
1803
Cullinan Oncology
CGEM
$987M
| $11.3K | ﹤0.01% |
1,495
-963
| -39% | -$7.74K |
2024 Q1
5 quarters
|
|
1804
Telephone and Data Systems
TDS
$3.98B
| $11.2K | ﹤0.01% |
316
-207
| -40% | -$7.26K |
2024 Q4
2 quarters
|
|
1805
Acadia Pharmaceuticals
ACAD
$3.38B
| $11.2K | ﹤0.01% |
519
-1,798
| -78% | -$33.4K |
2021 Q3
15 quarters
|
|
1806
Jasper Therapeutics
JSPR
$18.5M
| $11K | ﹤0.01% |
1,977
+920
| +87% | +$4.53K |
2025 Q1
1 quarter
|
|
1807
OraSure Technologies
OSUR
$274M
| $10.7K | ﹤0.01% |
3,569
| – | – |
2022 Q2
12 quarters
|
|
1808
Dorman Products
DORM
$3.55B
| $10.7K | ﹤0.01% |
87
-33
| -28% | -$4.01K |
2025 Q1
1 quarter
|
|
1809
Intrepid Potash
IPI
$437M
| $10.6K | ﹤0.01% |
298
+178
| +148% | +$6.07K |
2022 Q2
12 quarters
|
|
1810
Worthington Steel
WS
$1.84B
| $10.5K | ﹤0.01% |
353
-1,249
| -78% | -$32.2K |
2024 Q1
5 quarters
|
|
|
CIO
1811
DELISTED
City Office REIT
CIO
| $10.4K | ﹤0.01% |
1,953
| – | – |
2021 Q3
15 quarters
|
|
|
AVDL
1812
DELISTED
Avadel Pharmaceuticals
AVDL
| $10.4K | ﹤0.01% |
+1,175
| New | +$10.3K |
2025 Q2
0 quarters
|
|
1813
Central Garden & Pet Co Class A
CENTA
$2.19B
| $10.2K | ﹤0.01% |
325
+14
| +5% | +$437 |
2024 Q2
4 quarters
|
|
1814
Diamondback Energy
FANG
$55.2B
| $10.2K | ﹤0.01% |
74
-82
| -53% | -$11.4K |
2015 Q2
40 quarters
|
|
1815
DELISTED
Cantaloupe
CTLP
| $10.1K | ﹤0.01% |
922
-289,762
| -100% | -$2.51M |
2022 Q3
11 quarters
|
|
1816
Caribou Biosciences
CRBU
$51.5M
| $9.97K | ﹤0.01% |
7,917
-5,614
| -41% | -$5.52K |
2024 Q4
2 quarters
|
|
1817
Willdan Group
WLDN
$1.15B
| $9.75K | ﹤0.01% |
+156
| New | +$7.44K |
2025 Q2
0 quarters
|
|
1818
World Acceptance Corp
WRLD
$825M
| $9.74K | ﹤0.01% |
59
-19
| -24% | -$2.71K |
2013 Q2
48 quarters
|
|
1819
Kontoor Brands
KTB
$3.59B
| $9.7K | ﹤0.01% |
147
-140
| -49% | -$9.05K |
2024 Q3
3 quarters
|
|
1820
FuboTV Inc
FUBO
$265M
| $9.6K | ﹤0.01% |
+207
| New | +$7.75K |
2025 Q2
0 quarters
|
|
1821
Carter Bankshares
CARE
$703M
| $9.52K | ﹤0.01% |
549
+303
| +123% | +$4.79K |
2025 Q1
1 quarter
|
|
1822
Vaalco Energy
EGY
$644M
| $9.5K | ﹤0.01% |
+2,631
| New | +$9.14K |
2025 Q2
0 quarters
|
|
1823
BJ's Restaurants
BJRI
$1.24B
| $9.41K | ﹤0.01% |
+211
| New | +$8.33K |
2025 Q2
0 quarters
|
|
1824
Balchem Corp
BCPC
$5.33B
| $9.39K | ﹤0.01% |
59
-25
| -30% | -$4.05K |
2024 Q4
2 quarters
|
|
1825
Conduent
CNDT
$246M
| $9.31K | ﹤0.01% |
3,527
| – | – |
2019 Q3
23 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.